Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis

Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus

(2015) Shusuke Yagi et al.   Diabetes & Metabolism Journal

Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis

(2014) Y. G. Kim et al.   DIABETES OBESITY & METABOLISM

Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond

(2014) Niels Grarup et al.   DIABETOLOGIA

MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients

(2014) Guang Wang et al.   PLoS One

Efficacy of dipeptidyl-peptidase-4 inhibitors and impact onβ-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysis在亚洲人和白种人的2型糖尿病患者中DPP-4抑制剂的疗效及对β细胞功能的影响：一项meta分析

(2014) Xiaoling Cai et al.   Journal of Diabetes

Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis

(2013) Y. G. Kim et al.   DIABETOLOGIA

Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial

(2013) Linong Ji et al.   PLoS One

Exenatide Twice Daily: Analysis of Effectiveness and Safety Data Stratified by Age, Sex, Race, Duration of Diabetes, and Body Mass Index

(2012) Richard Pencek et al.   POSTGRADUATE MEDICINE

Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin

(2012) Anja Schweizer et al.   Diabetes Therapy

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

(2011) Hajime Maeda et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials

(2011) Matteo Monami et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

(2011) Soon Ae Kim et al.   Diabetes & Metabolism Journal

The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial

(2010) S. Zoungas et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE